Long-Term Outcomes of Absorb Bioresorbable Vascular Scaffold vs. Everolimus-Eluting Metallic Stent　― A Randomized Comparison Through 5 Years in Japan ―-Reference-Cited by-同舟云学术

Long-Term Outcomes of Absorb Bioresorbable Vascular Scaffold vs. Everolimus-Eluting Metallic Stent　― A Randomized Comparison Through 5 Years in Japan ―

Published:2020-04-24 Issue:5 Volume:84 Page:733-741
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kozuma Ken¹,Tanabe Kengo²,Hamazaki Yuji³,Okamura Takayuki⁴,Ando Jiro⁵,Ikari Yuji⁶,Nakagawa Yoshihisa⁷,Kusano Hajime⁸,Ediebah Divine⁸,Kimura Takeshi⁹,

Affiliation:

1. Department of Cardiology, Teikyo University

2. Department of Cardiology, Mitsui Memorial Hospital

3. Division of Cardiology, Ootakanomori Hospital

4. Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine

5. Department of Cardiovascular Medicine, The University of Tokyo Hospital

6. Department of Cardiology, Tokai University Hospital

7. Department of Cardiovascular Medicine, Shiga University of Medical Science

8. Abbott Vascular

9. Department of Cardiovascular Medicine/Graduate School of Medicine, Kyoto University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/84/5/84_CJ-19-1184/_pdf

Reference25 articles.

1. 1. Räber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y, et al. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: A prospective cohort study. Circulation 2012; 125: 1110–1121.

2. 2. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011; 57: 1314–1322.

3. 3. Brugaletta S, Gogas BD, Garcia-Garcia HM, Farooq V, Girasis C, Heo JH, et al. Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments. Circ J 2012; 76: 1616–1623.

4. 4. Lane JP, Perkins LE, Sheehy AJ, Pacheco EJ, Frie MP, Lambert BJ, et al. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries. JACC Cardiovasc Interv 2014; 7: 688–695.

5. 5. Serruys PW, Onuma Y, Garcia-Garcia HM, Muramatsu T, van Geuns RJ, de Bruyne B, et al. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: A multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention 2014; 9: 1271–1284.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial;Frontiers in Cardiovascular Medicine;2024-09-10

2. Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis;JACC: Cardiovascular Interventions;2024-08

3. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

4. Bioresorbable scaffolds: past and present. Clinical example of a 10-year follow-up of a patient with an implanted Absorb stent;Ateroscleroz;2024-07-05

5. Five-Year Outcomes of Bioresorbable Stent Therapy for Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Reviews in Cardiovascular Medicine;2024-06-28